J.S.P. Property Public Company Limited (JSP) - Total Liabilities
Based on the latest financial reports, J.S.P. Property Public Company Limited (JSP) has total liabilities worth ฿550.31 Million THB (≈ $17.15 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
J.S.P. Property Public Company Limited - Total Liabilities Trend (2013–2025)
This chart illustrates how J.S.P. Property Public Company Limited's total liabilities have evolved over time, based on quarterly financial data. See J.S.P. Property Public Company Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
J.S.P. Property Public Company Limited Competitors by Total Liabilities
The table below lists competitors of J.S.P. Property Public Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gencurix Inc
KQ:229000
|
Korea | ₩15.69 Billion |
|
ODTech Co. Ltd
KQ:080520
|
Korea | ₩7.53 Billion |
|
Esta Multi Usaha PT
JK:ESTA
|
Indonesia | Rp164.17 Billion |
|
CHAR Technologies Ltd
V:YES
|
Canada | CA$3.99 Million |
|
Besra Gold Inc
AU:BEZ
|
Australia | AU$44.34 Million |
|
BIOCERES CROP SOL.
F:0G4
|
Germany | €453.75 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$67.50 Million |
|
Daegu Dept Sto
KO:006370
|
Korea | ₩280.35 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down J.S.P. Property Public Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of J.S.P. Property Public Company Limited.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how J.S.P. Property Public Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for J.S.P. Property Public Company Limited (2013–2025)
The table below shows the annual total liabilities of J.S.P. Property Public Company Limited from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ฿536.56 Million ≈ $16.72 Million |
+20.81% |
| 2024-12-31 | ฿444.13 Million ≈ $13.84 Million |
+9.61% |
| 2023-12-31 | ฿405.17 Million ≈ $12.63 Million |
+44.51% |
| 2022-12-31 | ฿280.37 Million ≈ $8.74 Million |
-4.70% |
| 2021-12-31 | ฿294.21 Million ≈ $9.17 Million |
+2.10% |
| 2020-12-31 | ฿288.17 Million ≈ $8.98 Million |
+4.04% |
| 2019-12-31 | ฿276.98 Million ≈ $8.63 Million |
-15.10% |
| 2018-12-31 | ฿326.26 Million ≈ $10.17 Million |
+3.45% |
| 2017-12-31 | ฿315.39 Million ≈ $9.83 Million |
-95.70% |
| 2016-12-31 | ฿7.33 Billion ≈ $228.54 Million |
+92.93% |
| 2015-12-31 | ฿3.80 Billion ≈ $118.45 Million |
-3.86% |
| 2014-12-31 | ฿3.95 Billion ≈ $123.22 Million |
-0.73% |
| 2013-12-31 | ฿3.98 Billion ≈ $124.12 Million |
-- |
About J.S.P. Property Public Company Limited
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. engages in the research, development, manufacturing, and sales of pharmaceutical, dietary supplementary, traditional medicine, and herbal products in Thailand. It is also involved in manufacturing and selling hemodialysis products and supplies, purified water systems for industrial purposes, and related medical supplies; and services of… Read more